Table 1.
Baseline patient characteristics
| No. of patients | Mean (range) | % | |
|---|---|---|---|
| Total | 79 | ||
| Gender | |||
| Male | 38 | 48 | |
| Age | 58.4 (30–83) | ||
| Female | 41 | 52 | |
| Age | 54.8 (20–74) | ||
| Weight (kg) | 74.3 (43–142) | ||
| BMI (kg/m2) | 25.0 (15.6–45.1) | ||
| Height (cm) | 172 (152–196) | ||
| Karnofsky Performance Score | 89.4 (50–100) | ||
| Diagnosis | |||
| Carcinoid | 49 | 62 | |
| NET of unknown origin | 8 | 10 | |
| NET pancreas | 15 | 20 | |
| Gastrinoma | 1 | 1 | |
| Insulinoma | 1 | 1 | |
| Hürthle cell thyroid carcinoma | 3 | 4 | |
| Medullary thyroid carcinoma | 1 | 1 | |
| Paraganglioma | 1 | 1 | |
| Metastases | |||
| Liver | 66 | 84 | |
| Bone | 18 | 23 | |
| Prior therapy | |||
| Surgery | 36 | 46 | |
| Chemotherapy | 6 | 8 | |
| External beam radiotherapy | 3 | 4 | |
| Somatostatin analogue therapy | 36 | 46 | |
BMI body mass index, NET neuroendocrine tumour